A patient with lymphoma is receiving rituximab. When explaining possible side ef

Question

A patient with lymphoma is receiving rituximab. When explaining possible side effects to a patient, the nurse understands that side effects of this drug are: a. greatest with the fourth dose. b. related to the site of the target antigen. c. due to proteasome 265 inhibition. d. cumulative in nature. The International Agency for Research on Cancer publishes: a. evidence indicating increased occurrence of cancer among nurses. b. independent assessments of the carcinogenic risk of chemicals. c. definition, classification, and toxicity of hazardous drugs. d. safe level of occupational exposure to hazardous drugs.

Explanation / Answer

Question 53

Answer (d) Cumulative in nature

Rituximab administration affects the immune system so the side effects tend to be cumulative in nature. It leads to a large number of side effects including cardiac arrest. Severe side effects are reported for treatment with Rituximab including low white blood count, the occurrence of various infections etc.

Question 54

Answer (b) Independent assessment of the carcinogenic risk of chemicals.

International Agency for Research on Cancer (IARC) is an interdisciplinary agency working towards identifying the causes of cancer and their prevention. The agency makes an evaluation of carcinogenic risk of insecticides, herbicides, nano materials certain fibres, solvents, chemicals etc. They bring out various reports/monographs on the various carcinogenic effects of different kinds of substances.

Related Questions

Navigate

• Browse (All)
• Browse A
• Subjects

---

---

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.